Linked Life Data

11920396

Source:http://linkedlifedata.com/resource/pubmed/id/11920396

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2002-3-28
pubmed:abstractText
To evaluate the efficacy and safety of anakinra in combination with methotrexate (MTX) in patients with active rheumatoid arthritis (RA).
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0004-3591
pubmed:author
pubmed:issnType
Print
pubmed:volume
46
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
614-24
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11920396-Antibodies, pubmed-meshheading:11920396-Antirheumatic Agents, pubmed-meshheading:11920396-Arthritis, Rheumatoid, pubmed-meshheading:11920396-Blood Sedimentation, pubmed-meshheading:11920396-Dose-Response Relationship, Drug, pubmed-meshheading:11920396-Double-Blind Method, pubmed-meshheading:11920396-Drug Therapy, Combination, pubmed-meshheading:11920396-Female, pubmed-meshheading:11920396-Humans, pubmed-meshheading:11920396-Interleukin 1 Receptor Antagonist Protein, pubmed-meshheading:11920396-Male, pubmed-meshheading:11920396-Methotrexate, pubmed-meshheading:11920396-Middle Aged, pubmed-meshheading:11920396-Recombinant Proteins, pubmed-meshheading:11920396-Safety, pubmed-meshheading:11920396-Severity of Illness Index, pubmed-meshheading:11920396-Sialoglycoproteins, pubmed-meshheading:11920396-Treatment Outcome
pubmed:year
2002
pubmed:articleTitle
Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial.
pubmed:affiliation
Department of Rheumatology, St. Paul Medical Center, Dallas, Texas 75235, USA. stanleycohen@radiantresearch.com
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study